Avermectin is a widely used insecticide for pest control, such as the Plutella xylostella. Despite its efficacy in pest management, concerns have been raised regarding its effect on non-target species, such as the important economic insect silkworm (Bombyx mori). We aimed to investigate the effects of avermectin application on the 3D genome architecture of silkworm midgut using high-throughput techniques such as high-throughput chromosome conformation capture (Hi-C) coupled with RNA sequencing (RNA-seq) and Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq). Midgut tissue samples, during the fifth instar and three days, were collected from silkworm larvae fed mulberry leaves (control group) and leaves soaked in avermectin solution for 12 h (experimental group). Our findings revealed that avermectin treatment led to significant changes, including 386 differentially expressed genes (252 up-regulated, 134 down-regulated) and increased chromatin accessibility, particularly those involved in immune response, metabolism, and cellular stress pathways. The Hi-C data revealed more intense spatial interactions in the experimental group, leading to increased expression of detoxification proteins like ABC transporter. This study provides important insights into the molecular basis of pesticide resistance and a foundational basis for further research on the genetic and epigenetic mechanisms of insect stress responses.
Genome editing is a promising therapeutic strategy for genetic disorders by modifying the genome precisely, especially the CRISPR/Cas9 system. However, a major limitation of CRISPR/Cas9 in gene therapy is the biosafety issues caused by off-target effects. Compounds that can modulate the genome editing efficiency of the CRISPR/Cas9 system, especially those reducing the off-target effects, are potentially useful pharmacological tools for improving the effectiveness and safety of genome editing. Here, we performed high-throughput screening in HEK 293FT cells to discover compounds that decrease or increase the genome editing efficiency of the CRISPR/Cas9 system from 9930 compounds. After two rounds of screening, we identified that CP-724714, a ErbB2 (HER2) tyrosine kinase inhibitor, decreased the CRISPR/Cas9 efficiency and reduced the off-target effects by suppressing the efficiency of CRISPR/Cas9, and was thus named a CRISPR decelerator (or inhibitor), while Clofarabine, a DNA synthesis inhibitor, increased the efficiency of CRISPR/Cas9, and was named a CRISPR accelerator. We further identified four compounds (Tranilast, Cerulenin, Rosolic acid and Resveratrol) that affected the efficiency of single-strand annealing (SSA) repair. Among them, Tranilast, Cerulenin and Rosolic acid are potential SSA decelerators, while Resveratrol is a potential SSA accelerator. These identified compounds may be useful in optimizing mammalian genetic manipulation techniques.